GRI Bio, Inc. - GRI

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$161K
QoQ value delta ($000)
+$98K (+155.56%)
Implied price effect (QoQ)
-22.9%
Shares
Total shares
93,582
QoQ shares delta
+65,349 (+231.46%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (GRI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
HRT FINANCIAL LP 50 28,784 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 37 21,368 0.0%
GEODE CAPITAL MANAGEMENT, LLC 24 13,869 0.0%
CITADEL ADVISORS LLC 23 13,376 0.0%
MORGAN STANLEY 15 8,737 0.0%
UBS Group AG 8 4,920 0.0%
Tower Research Capital LLC (TRC) 4 2,434 0.0%
BARCLAYS PLC 0 83 0.0%
DANSKE BANK A/S 0 2 0.0%
Caitong International Asset Management Co., Ltd 0 2 0.0%
BlackRock, Inc. 0 7 0.0%